USD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$3.57M
Market Cap
-
P/E Ratio
-45.26
EPS
$8.93
52 Week High
$1.65
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $44M |
| Total Revenue | $65M |
| Cost Of Revenue | $21M |
| Costof Goods And Services Sold | $21M |
| Operating Income | -$27M |
| Selling General And Administrative | $36M |
| Research And Development | $6.7M |
| Operating Expenses | $71M |
| Investment Income Net | - |
| Net Interest Income | -$7.7M |
| Interest Income | - |
| Interest Expense | $7.7M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.9M |
| Income Before Tax | -$48M |
| Income Tax Expense | -$611K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$47M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$40M |
| Ebitda | -$36M |
| Net Income | -$47M |
| Field | Value (USD) |
|---|---|
| Total Assets | $68M |
| Total Current Assets | $49M |
| Cash And Cash Equivalents At Carrying Value | $4.3M |
| Cash And Short Term Investments | $4.3M |
| Inventory | $18M |
| Current Net Receivables | $19M |
| Total Non Current Assets | $20M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $5M |
| Intangible Assets Excluding Goodwill | $5M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $7.4M |
| Other Non Current Assets | - |
| Total Liabilities | $65M |
| Total Current Liabilities | $30M |
| Current Accounts Payable | $6.5M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $9.6M |
| Total Non Current Liabilities | $35M |
| Capital Lease Obligations | $3.3M |
| Long Term Debt | $31M |
| Current Long Term Debt | $8.3M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $43M |
| Other Current Liabilities | $9.9M |
| Other Non Current Liabilities | $511K |
| Total Shareholder Equity | $2.4M |
| Treasury Stock | - |
| Retained Earnings | -$309M |
| Common Stock | $30K |
| Common Stock Shares Outstanding | $709K |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$11M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3.9M |
| Capital Expenditures | $123K |
| Change In Receivables | - |
| Change In Inventory | $4.5M |
| Profit Loss | - |
| Cashflow From Investment | -$123K |
| Cashflow From Financing | $10M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$47M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $44M |
| Total Revenue | $65M |
| Cost Of Revenue | $21M |
| Costof Goods And Services Sold | $21M |
| Operating Income | -$27M |
| Selling General And Administrative | $36M |
| Research And Development | $6.7M |
| Operating Expenses | $71M |
| Investment Income Net | - |
| Net Interest Income | -$7.7M |
| Interest Income | - |
| Interest Expense | $7.7M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.9M |
| Income Before Tax | -$48M |
| Income Tax Expense | -$611K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$47M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$40M |
| Ebitda | -$36M |
| Net Income | -$47M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Venus Concept Inc. (VERO) is a leading medical technology company headquartered in Toronto, Canada, specializing in innovative minimally invasive and non-invasive solutions within the medical aesthetics and hair restoration sectors. The company is dedicated to enhancing patient outcomes by leveraging cutting-edge technology and providing extensive support to healthcare providers globally. With a strong focus on research and development, Venus Concept is strategically positioned to redefine aesthetic treatment options, solidifying its role as a significant player in the dynamic healthcare landscape.